Ingredion INGR
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$3.15M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 32.6% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 6.54% to 7.24% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| American Century Investment Management | Mutual Fund | 2026/Q3 | +863,301 | 3.4% |
| Deka Investment GmbH | Mutual Fund | 2026/Q3 | +417,857 | 1.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +350,069 | 11.1% |
| Equity Investment Corporation | Mutual Fund | 2026/Q3 | +214,536 | 1.7% |
| Mackenzie Financial Corporation | Mutual Fund | 2026/Q3 | +196,092 | 0.8% |
| Barclays PLC | Public Company | 2026/Q3 | +150,486 | 0.4% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +148,739 | 5.6% |
| Creative Planning, Inc. | Mutual Fund | 2026/Q3 | +93,838 | 0.3% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +80,983 | 0.2% |
| Morgan Stanley | Public Company | 2026/Q3 | +71,997 | 1.8% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +71,997 | 1.8% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +991,922 | 2.0% |
| Brandes Investment Partners, LP | Mutual Fund | 2026/Q3 | +661,262 | 2.0% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +354,758 | 1.0% |
| Mackenzie Financial Corporation | Mutual Fund | 2026/Q3 | +265,439 | 0.5% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 29 Oct 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +18 | – | 13,598 |
| 14 Oct 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | – | 13,465 |
| 14 Oct 2026 | Diego Reynoso | Chief Financial Officer | Other Acquisition | +12,660 | $97.27 | 12,660 |
| 29 Sep 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +18 | – | 13,447 |
| 29 Sep 2026 | Charles Magro | Independent Director | Other Derivative Acquisition | +266 | – | 772 |
| 14 Sep 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | – | 13,429 |
| 14 Sep 2026 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +28 | – | 1,895 |
| 30 Aug 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +16 | – | 13,411 |
| 30 Aug 2026 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +33 | – | 1,867 |
| 13 Aug 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +16 | – | 13,394 |
| 13 Aug 2026 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +32 | – | 1,834 |
| 4 Aug 2026 | David Fischer | Independent Director | Open Market Disposition | -1,662 | $102.31 | 430 |
| 30 Jul 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | – | 13,378 |
| 30 Jul 2026 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +34 | – | 1,801 |
| 14 Jul 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | – | 13,254 |
| 14 Jul 2026 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +34 | – | 1,753 |
| 30 Jun 2026 | Kenneth Escoe | Independent Director | Other Acquisition | +1,516 | $98.97 | 1,516 |
| 29 Jun 2026 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +18 | – | 13,236 |
| 29 Jun 2026 | Charles Magro | Independent Director | Other Derivative Acquisition | +265 | – | 500 |
| 29 Jun 2026 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +36 | – | 1,719 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 4,562,711 | 7.2% | 6.4 |
| 15 Oct 2026 | 4,675,789 | 7.4% | 7.1 |
| 30 Sep 2026 | 4,806,129 | 7.6% | 7.2 |
| 15 Sep 2026 | 4,517,645 | 7.2% | 7.2 |
| 31 Aug 2026 | 4,198,333 | 6.7% | 8.2 |
| 14 Aug 2026 | 4,127,503 | 6.5% | 5.3 |
No comments yet — be the first to weigh in on INGR.
Sign in to join the discussion.